Precision Biosciences (DTIL) Receivables (2018 - 2025)
Historic Receivables for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $3.8 million.
- Precision Biosciences' Receivables rose 192340.43% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 192340.43%. This contributed to the annual value of $229000.0 for FY2024, which is 7458.38% down from last year.
- Precision Biosciences' Receivables amounted to $3.8 million in Q3 2025, which was up 192340.43% from $4000.0 recorded in Q1 2025.
- Precision Biosciences' 5-year Receivables high stood at $50.5 million for Q2 2022, and its period low was $4000.0 during Q1 2025.
- For the 5-year period, Precision Biosciences' Receivables averaged around $4.7 million, with its median value being $570000.0 (2021).
- Its Receivables has fluctuated over the past 5 years, first soared by 1024979.51% in 2022, then plummeted by 9897.44% in 2025.
- Quarter analysis of 5 years shows Precision Biosciences' Receivables stood at $488000.0 in 2021, then surged by 47.54% to $720000.0 in 2022, then grew by 25.14% to $901000.0 in 2023, then crashed by 74.58% to $229000.0 in 2024, then skyrocketed by 1561.14% to $3.8 million in 2025.
- Its Receivables was $3.8 million in Q3 2025, compared to $4000.0 in Q1 2025 and $229000.0 in Q4 2024.